$MRNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Moderna, Inc.. Get notifications about new insider transactions in Moderna, Inc. for free.
Page: < prev 1 ... 9 10 11 12 13
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.57 | 2,557 | 50,040 | 7,972,046 | 8 M to 8 M (-0.03 %) |
Jan 03 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.53 | 11,046 | 215,728 | 817,420 | 828.5 K to 817.4 K (-1.33 %) |
Dec 23 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.69 | 11,046 | 217,496 | 828,466 | 839.5 K to 828.5 K (-1.32 %) |
Dec 16 2019 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 18.54 | 100,000 | 1,854,000 | 104,770 | 204.8 K to 104.8 K (-48.84 %) |
Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | J | 0.00 | 42,132 | 0 | 6,762,500 | 6.7 M to 6.8 M (+0.63 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | KANIA EDWIN M JR | 10% Owner | Sell | S | 18.81 | 100,000 | 1,880,840 | 498,847 | 598.8 K to 498.8 K (-16.70 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 38,366 | 715,710 | 8,190,766 | 8.2 M to 8.2 M (-0.47 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 199,935 | 3,729,747 | 31,216,399 | 31.4 M to 31.2 M (-0.64 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 4,092 | 77,579 | 8,229,132 | 8.2 M to 8.2 M (-0.05 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 21,325 | 404,292 | 31,416,334 | 31.4 M to 31.4 M (-0.07 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 27,714 | 526,408 | 8,233,224 | 8.3 M to 8.2 M (-0.34 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 144,423 | 2,743,199 | 31,437,659 | 31.6 M to 31.4 M (-0.46 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,735,720 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,207,658 | 0 | 8,260,938 | 9.5 M to 8.3 M (-12.75 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 6,292,342 | 0 | 31,582,082 | 37.9 M to 31.6 M (-16.61 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 17,889 | 337,565 | 17,889 | |
Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 39,720 | 749,516 | 39,720 | |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,358 | 0 | 0 | |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,357 | 0 | 0 | |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.93 | 1,306 | 27,335 | 1,362,510 | 1.4 M to 1.4 M (-0.10 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.39 | 147,528 | 3,008,096 | 1,363,816 | 1.5 M to 1.4 M (-9.76 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 19.34 | 89,698 | 1,734,759 | 1,511,344 | 1.6 M to 1.5 M (-5.60 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,358 | 4,733,949 | 1,601,042 | 1.4 M to 1.6 M (+16.72 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,357 | 4,733,928 | 1,371,684 | 1.1 M to 1.4 M (+20.08 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.95 | 200 | 4,190 | 850,558 | 850.8 K to 850.6 K (-0.02 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.43 | 6,200 | 126,666 | 850,758 | 857 K to 850.8 K (-0.72 %) |
Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.42 | 4,646 | 90,225 | 856,958 | 861.6 K to 857 K (-0.54 %) |
Dec 03 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.54 | 11,046 | 226,885 | 861,604 | 872.7 K to 861.6 K (-1.27 %) |
Nov 25 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.48 | 11,046 | 226,222 | 872,650 | 883.7 K to 872.7 K (-1.25 %) |
Nov 22 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Option Exercise | M | 0.04 | 200,000 | 8,000 | 502,752 | |
Nov 22 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Sell | S | 20.18 | 200,000 | 4,036,000 | 3,924 | 203.9 K to 3.9 K (-98.08 %) |
Nov 22 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Buy | M | 0.04 | 200,000 | 8,000 | 203,924 | 3.9 K to 203.9 K (+5,096.84 %) |
Nov 19 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.38 | 336 | 6,512 | 883,696 | 884 K to 883.7 K (-0.04 %) |
Nov 19 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.02 | 10,710 | 203,704 | 884,032 | 894.7 K to 884 K (-1.20 %) |
Nov 19 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.38 | 336 | 6,512 | 883,696 | 884 K to 883.7 K (-0.04 %) |
Nov 19 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.02 | 10,710 | 203,704 | 884,032 | 894.7 K to 884 K (-1.20 %) |
Nov 12 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 17.38 | 11,046 | 191,979 | 894,742 | 905.8 K to 894.7 K (-1.22 %) |
Nov 05 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 16.68 | 4,500 | 75,060 | 905,788 | 910.3 K to 905.8 K (-0.49 %) |
Nov 05 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 15.66 | 6,546 | 102,510 | 910,288 | 916.8 K to 910.3 K (-0.71 %) |
Sep 24 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Gift | G | 0.00 | 5,000 | 0 | 1,142,327 | 1.1 M to 1.1 M (-0.44 %) |
Sep 24 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Gift | G | 0.00 | 5,000 | 0 | 1,142,327 | 1.1 M to 1.1 M (-0.44 %) |
Sep 18 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Option Exercise | M | 0.04 | 100,000 | 4,000 | 702,752 | |
Sep 18 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Sell | S | 17.63 | 100,000 | 1,763,000 | 3,924 | 103.9 K to 3.9 K (-96.22 %) |
Sep 18 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Buy | M | 0.04 | 100,000 | 4,000 | 103,924 | 3.9 K to 103.9 K (+2,548.42 %) |
Jun 28 2019 | MRNA | Moderna, Inc. | Ruiz Israel | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | Slaoui Moncef | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | HUTT PETER BARTON | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | Berenson Stephen | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Jun 28 2019 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
Mar 11 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | A | 20.93 | 593,592 | 12,423,881 | 593,592 | |
Mar 11 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | A | 20.93 | 211,997 | 4,437,097 | 211,997 | |
Mar 11 2019 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | A | 20.93 | 339,195 | 7,099,351 | 339,195 | |
Mar 11 2019 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | A | 20.93 | 339,195 | 7,099,351 | 339,195 | |
Mar 11 2019 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | A | 20.93 | 254,396 | 5,324,508 | 254,396 | |
Mar 11 2019 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | A | 20.93 | 186,092 | 3,894,906 | 186,092 | |
Mar 11 2019 | MRNA | Moderna, Inc. | LEE JENNIFER LING | Chief Accounting Of ... | Option Exercise | A | 20.93 | 25,097 | 525,280 | 25,097 | |
Mar 11 2019 | MRNA | Moderna, Inc. | LEE JENNIFER LING | Chief Accounting Of ... | Grant | A | 0.00 | 4,780 | 0 | 4,780 | 0 to 4.8 K |
Dec 13 2018 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | C | 0.00 | 458 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | C | 0.00 | 458 | 0 | 2,096,530 | 2.1 M to 2.1 M (+0.02 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | C | 0.00 | 13,679 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Buy | C | 0.00 | 13,679 | 0 | 44,344 | 30.7 K to 44.3 K (+44.61 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | C | 0.00 | 4,559 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Buy | C | 0.00 | 4,559 | 0 | 11,466,961 | 11.5 M to 11.5 M (+0.04 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Option Exercise | C | 0.00 | 367,776 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Buy | C | 0.00 | 367,776 | 0 | 367,776 | 0 to 367.8 K |
Dec 13 2018 | MRNA | Moderna, Inc. | Ruiz Israel | Director | Option Exercise | C | 0.00 | 4,559 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Ruiz Israel | Director | Buy | C | 0.00 | 4,559 | 0 | 4,559 | 0 to 4.6 K |
Dec 13 2018 | MRNA | Moderna, Inc. | Berenson Stephen | Director | Option Exercise | C | 0.00 | 22,798 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Berenson Stephen | Director | Buy | C | 0.00 | 22,798 | 0 | 22,798 | 0 to 22.8 K |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 21,496 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 85,989 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,428,432 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 5,713,739 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 6,195,632 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 24,782,551 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,823,036 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 7,292,145 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 21,496 | 0 | 9,468,596 | 9.4 M to 9.5 M (+0.23 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 85,989 | 0 | 37,874,424 | 37.8 M to 37.9 M (+0.23 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 1,428,432 | 0 | 9,447,100 | 8 M to 9.4 M (+17.81 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 5,713,739 | 0 | 37,788,435 | 32.1 M to 37.8 M (+17.81 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 6,195,632 | 0 | 8,018,668 | 1.8 M to 8 M (+339.85 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 24,782,551 | 0 | 32,074,696 | 7.3 M to 32.1 M (+339.85 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 1,823,036 | 0 | 1,823,036 | 0 to 1.8 M |
Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 7,292,145 | 0 | 7,292,145 | 0 to 7.3 M |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 22,935 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 4,587 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 18,591 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 53,823 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,428,427 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 7,744,542 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | C | 0.00 | 4,557,591 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 22,935 | 0 | 7,974,603 | 8 M to 8 M (+0.29 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 4,587 | 0 | 9,249,970 | 9.2 M to 9.2 M (+0.05 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 18,591 | 0 | 9,245,383 | 9.2 M to 9.2 M (+0.20 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 53,823 | 0 | 9,226,792 | 9.2 M to 9.2 M (+0.59 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 1,428,427 | 0 | 9,172,969 | 7.7 M to 9.2 M (+18.44 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 7,744,542 | 0 | 7,744,542 | 0 to 7.7 M |
Dec 13 2018 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | C | 0.00 | 4,557,591 | 0 | 7,951,668 | 3.4 M to 8 M (+134.28 %) |
Dec 13 2018 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | C | 0.00 | 458 | 0 | 0 | |
Dec 13 2018 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | C | 0.00 | 458 | 0 | 1,147,327 | 1.1 M to 1.1 M (+0.04 %) |